Neupath Health Stock Working Capital
| NPTH Stock | CAD 0.20 0.02 11.11% |
NeuPath Health fundamentals help investors to digest information that contributes to NeuPath Health's financial success or failures. It also enables traders to predict the movement of NeuPath Stock. The fundamental analysis module provides a way to measure NeuPath Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuPath Health stock.
Net Working Capital is likely to climb to about 1.6 M in 2024. Change In Working Capital is likely to climb to about 582.8 K in 2024. NeuPath | Working Capital |
NeuPath Health Company Working Capital Analysis
NeuPath Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current NeuPath Health Working Capital | 1.51 M |
Most of NeuPath Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeuPath Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
NeuPath Capital Lease Obligations
Capital Lease Obligations |
|
Based on the company's disclosures, NeuPath Health has a Working Capital of 1.51 M. This is 99.65% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The working capital for all Canada stocks is 99.9% higher than that of the company.
NeuPath Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeuPath Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeuPath Health could also be used in its relative valuation, which is a method of valuing NeuPath Health by comparing valuation metrics of similar companies.NeuPath Health is currently under evaluation in working capital category among related companies.
NeuPath Fundamentals
| Return On Equity | -0.0088 | ||||
| Return On Asset | 0.0064 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 18.3 M | ||||
| Shares Outstanding | 56.29 M | ||||
| Shares Owned By Insiders | 0.88 % | ||||
| Shares Owned By Institutions | 19.35 % | ||||
| Number Of Shares Shorted | 102 | ||||
| Price To Book | 0.43 X | ||||
| Price To Sales | 0.14 X | ||||
| Revenue | 66.1 M | ||||
| Gross Profit | 10.82 M | ||||
| EBITDA | 1.62 M | ||||
| Net Income | (107 K) | ||||
| Cash And Equivalents | 7.48 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 195 K | ||||
| Debt To Equity | 0.67 % | ||||
| Current Ratio | 1.27 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | 3.03 M | ||||
| Short Ratio | 0.15 X | ||||
| Target Price | 0.5 | ||||
| Number Of Employees | 156 | ||||
| Beta | 0.76 | ||||
| Market Capitalization | 10.13 M | ||||
| Total Asset | 41.78 M | ||||
| Retained Earnings | (26.02 M) | ||||
| Working Capital | 1.51 M | ||||
| Net Asset | 41.78 M |
About NeuPath Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeuPath Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuPath Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuPath Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with NeuPath Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuPath Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to NeuPath Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuPath Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuPath Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuPath Health to buy it.
The correlation of NeuPath Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuPath Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuPath Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuPath Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuPath Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for NeuPath Stock analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |